They ran four parallel studies based on different patient profiles: ADM trial: Patients with type 2 diabetes (T2D), comparing newer GLP-1 RAs to older GLP-1 RAs, sulfonylureas, and other anti-diabetic medications (ADMs)
Professional society guidelines now recommend GLP therapy for cardiovascular risk reduction in patients with type 2 diabetes and established cardiovascular disease or multiple cardiac risk factors
Wondering about Jardiance vs metformin for type 2 diabetes
Additional benefits include anti-inflammatory properties, enhanced collagen production, and improved skin elasticity
83% of peptide-aware Americans want the FDA to make peptides more accessible Days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding, a new survey suggests thats what Americans want